Shire plc becomes OBN’s first Corporate Patron

OBN, the not-for-profit business network which provides comprehensive support for biotech and medtech companies in the Oxford and South-East England biocluster has announced that global specialty pharmaceutical company Shire has become the network's first Corporate Patron.

OBN, the not-for-profit business network which provides comprehensive support for biotech and medtech companies in the Oxford and South-East England biocluster has announced that global specialty pharmaceutical company Shire has become the network’s first Corporate Patron. Shire will support OBN in meeting the aims of its initiative: to provide networking, partnering, group purchasing services, advice and better communication across the life sciences industry.

Shire’s great wealth of sector experience will also be employed on the OBN Advisory Board, where David Colpman, Senior Vice President of Business Development from Shire will become a valued new member. In addition, Shire will continue to be a key supporter of the Network’s annual partnering and investment conference BioTrinity.

As a Corporate Patron Shire will also host a BioTuesday, OBN’s monthly networking meeting, at its UK headquarters in Basingstoke on 26th October 2010, entitled &ldquo